NIM
GILD icon

NEOS Investment Management’s Gilead Sciences GILD Stock Holding History

NEOS Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$120M Buy
950,430
+96,425
+11% +$12.7M 0.44% 39
2026
Q1 		$119M Buy
854,005
+135,496
+19% +$19M 0.6% 30
2025
Q4 		$88.2M Buy
718,509
+141,390
+24% +$17.2M 0.51% 34
2025
Q3 		$64.1M Buy
577,119
+215,619
+60% +$24.5M 0.48% 33
2025
Q2 		$40.1M Buy
361,500
+100,170
+38% +$10.7M 0.5% 37
2025
Q1 		$29.3M Buy
261,330
+55,501
+27% +$5.73M 0.56% 34
2024
Q4 		$19M Buy
205,829
+53,891
+35% +$4.85M 0.45% 41
2024
Q3 		$12.7M Buy
151,938
+29,422
+24% +$2.25M 0.38% 51
2024
Q2 		$8.41M Buy
122,516
+42,211
+53% +$2.82M 0.35% 52
2024
Q1 		$5.88M Buy
80,305
+14,494
+22% +$1.11M 0.36% 50
2023
Q4 		$5.33M Buy
65,811
+8,422
+15% +$655K 0.5% 39
2023
Q3 		$4.3M Buy
+57,389
New +$4.41M 0.55% 36

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NEOS Investment Management's GILD Position: Q2 2026 in Review

NEOS Investment Management increased its Gilead Sciences (GILD) stake by 11% in Q2 2026, buying an estimated $12.7M and bringing the position to 950,430 shares worth $120M. The position accounts for 0.44% of the portfolio, ranked #39.

NEOS Investment Management first reported a position in GILD in Q3 2023 and has held it in 12 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • NEOS Investment Management held 950,430 shares of Gilead Sciences worth $120M as of Q2 2026.
  • NEOS Investment Management bought 96,425 Gilead Sciences shares in Q2 2026, an estimated $12.7M.
  • Gilead Sciences made up 0.44% of NEOS Investment Management's portfolio in Q2 2026, its #39 holding.
  • NEOS Investment Management first reported a position in Gilead Sciences in Q3 2023 and has held it in 12 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on NEOS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.